Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2015 Oct 1.

Published in final edited form as: Inflammopharmacology. 2014 Aug 19;22(5):295–303. doi: 10.1007/s10787-014-0214-z

Fig. 2 — Serum Cytokine Levels: Using a bead array assay we measured CCL2, IL17 and panels of Th₁ and Th₂ cytokines. a) There was no significant difference in the level of CCL2 across cohorts. b) Levels of IL17 were significantly reduced in both cohorts who were current Cannabis users (non-naïve), compared to naïve subjects c,d) Levels of both Th₁ and Th₂ cytokines were significantly suppressed (undetectable in some cases) in current Cannabis users compared to naïve subjects (2-way ANOVA followed by Bonferroni’s post-test).

Fig. 2 — Serum Cytokine Levels: Using a bead array assay we measured CCL2, IL17 and panels of Th₁ and Th₂ cytokines. a) There was no significant difference in the level of CCL2 across cohorts. b) Levels of IL17 were significantly reduced in both cohorts who were current Cannabis users (non-naïve), compared to naïve subjects c,d) Levels of both Th₁ and Th₂ cytokines were significantly suppressed (undetectable in some cases) in current Cannabis users compared to naïve subjects (2-way ANOVA followed by Bonferroni’s post-test).